首页> 美国政府科技报告 >Multimodality Image-Guided HDR/IMRT in Prostate Cancer: Combined Molecular Targeting Using Nanoparticle MR, 3D MRSI, and 11C Acetate PET Imaging
【24h】

Multimodality Image-Guided HDR/IMRT in Prostate Cancer: Combined Molecular Targeting Using Nanoparticle MR, 3D MRSI, and 11C Acetate PET Imaging

机译:前列腺癌中的多模态图像引导HDR / ImRT:使用纳米颗粒mR,3D mRsI和11C醋酸酯pET成像的组合分子靶向

获取原文

摘要

The purpose of the award was to provide funding for the development of a multimodality prostate cancer clinical trial. A clinical protocol was developed along with a supporting infrastructure to begin the trial. A submission for funding under the DOD Prostate Cancer Clinical Trial Award mechanism; however the project was not funded. Submission under an alternative funding mechanism is pending collection of more preliminary data and optimization of C-11 acetate synthesis method.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号